WGS Stock Price | GeneDx Holdings Corp. P/E, Revenue, EPS, & Forecasts

GeneDx Holdings Corp. • WGS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About GeneDx Holdings Corp.

Ticker

WGS

Trading on

NASDAQ

ISIN

US81663L2007

Industry

Diagnostics & Research

Sector

Healthcare

CEO

Katherine A. Stueland

Headquarters

North Tower, Stamford, CT, United States, 06902

Employees

1,000

Website

genedx.com

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Metrics

BasicAdvanced

Market cap

$1.91B

P/E ratio

EPS

-$1.39

Dividend Yield

0.00%

Beta

2.01

Forward P/E ratio

EBIDTA

$9.1M

Ex dividend date

Price & volume

Market cap

$1.91B

Average daily volume

0.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

5.79

Price to book

7.43

Earnings

EPS

-$1.39

EPS estimate (current quarter)

$0.09

EPS estimate (next quarter)

$0.20

EBITDA

$9.1M

Revenues (TTM)

$330M

Revenues per share (TTM)

$12.04

Technicals

Beta

2.01

52-week High

$117.75

52-week Low

$24.91

50-day moving average

$76.68

200-day moving average

$73.76

Short ratio

2.19

Short %

25.72%

Management effectiveness

ROE (TTM)

-16.61%

ROA (TTM)

-1.84%

Profit margin

-11.69%

Gross profit margin

$215M

Operating margin

-5.22%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

39.60%

Share stats

Outstanding Shares

28.5M

Float

19.8M

Insiders %

12.29%

Institutions %

103.25%

Analyst Insights & forecasts

84% Buy

16% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$95.04

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.10

-$0.30

66.67%

Q2 • 24Beat

$0.04

-$0.21

119.05%

Q3 • 24Beat

$0.64

$0.10

515.00%

Q4 • 24Beat

$0.27

-$0.67

140.78%

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$95.6M

$5.4M

5.69%

Q4 • 24

$87.1M

$-6.5M

-7.49%

Q1 • 25

-8.91%

-220.06%

-231.81%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$419M

$174M

41.52%

Q4 • 24

$446M

$189M

42.34%

Q1 • 25

6.45%

8.55%

1.97%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-3.2M

$-0.5M

$31M

$-6.2M

Q4 • 24

$10.2M

$-9.4M

$13.7M

$4.1M

Q1 • 25

-419.89%

1,712.72%

-55.78%

-165.02%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a GeneDx Holdings Corp. share?

GeneDx Holdings Corp. shares are currently traded for undefined per share.

How many shares does GeneDx Holdings Corp. have?

GeneDx Holdings Corp. currently has 28.5M shares.

Does GeneDx Holdings Corp. pay dividends?

No, GeneDx Holdings Corp. doesn't pay dividends.

What is GeneDx Holdings Corp. 52 week high?

GeneDx Holdings Corp. 52 week high is $117.75.

What is GeneDx Holdings Corp. 52 week low?

GeneDx Holdings Corp. 52 week low is $24.91.

What is the 200-day moving average of GeneDx Holdings Corp.?

GeneDx Holdings Corp. 200-day moving average is $73.76.

Who is GeneDx Holdings Corp. CEO?

The CEO of GeneDx Holdings Corp. is Katherine A. Stueland.

How many employees GeneDx Holdings Corp. has?

GeneDx Holdings Corp. has 1,000 employees.

What is the market cap of GeneDx Holdings Corp.?

The market cap of GeneDx Holdings Corp. is $1.91B.

What is the P/E of GeneDx Holdings Corp.?

The current P/E of GeneDx Holdings Corp. is null.

What is the EPS of GeneDx Holdings Corp.?

The EPS of GeneDx Holdings Corp. is -$1.39.

What is the PEG Ratio of GeneDx Holdings Corp.?

The PEG Ratio of GeneDx Holdings Corp. is null.

What do analysts say about GeneDx Holdings Corp.?

According to the analysts GeneDx Holdings Corp. is considered a buy.